姓名 | 陈心 |
出生年月 | 1981年7月 |
单位 | 武汉大学人民医院肿瘤科 |
所属学科 | 临床医学-肿瘤学 |
职务、职称及头衔 | 副主任医师,硕士生导师 |
rm001275@whu.edu.cn | |
联系方式 | 027-88041911转85015或18171235882 |
研究方向 |
1.恶性肿瘤的精准放射治疗 2.脂质代谢与肿瘤免疫微环境 |
个人简介 | 主要从事恶性肿瘤的诊治与科研工作,曾赴美国密歇根大学进行肿瘤免疫治疗相关研究。在中山大学肿瘤防治中心研修放射治疗。主持及参与多项国家/省/校级自然科学基金,发表国内外论文30篇。申请专利一项。参与培养硕士生4名。目前任武汉大学医学院班级导师和学习导师。 |
学术任职与荣誉 |
中国抗癌协会肿瘤放射防护专业委员会委员 湖北省微循环学会肿瘤专业委员会常务委员 湖北省抗癌协会鼻咽癌专业委员委员会委员 湖北省抗癌协会癌症康复与姑息治疗专业委员会委员 湖北省临床肿瘤学会免疫治疗专家委员会委员 湖北省临床肿瘤学会淋巴瘤专家委员会 委员 |
教育履历 |
1997/9–2002/6,华中科技大学同济医学院,获学士学位 2003/9–2008/6,华中科技大学同济医学院,获博士学位 |
工作履历 |
2008/07-2009/11,武汉大学人民医院,住院医师 2009/12-2015/10,武汉大学人民医院,主治医师 2015/10-2016/11,美国密歇根大学,肿瘤中心,访问学者 2016/12 - 2017/11,武汉大学人民医院,主治医师 2017/12 -至今, 武汉大学人民医院,副主任医师 |
成果获奖 | 《靶向及智能放疗质控体系创新与应用》2020年湖北省科技进步二等奖 |
代表性论著 |
1.Liao
F#*, Chen X#, Peng P, Dong W*. RWR-algorithm-based dissection of
microRNA-506-3p and microRNA-140-5p as radiosensitive biomarkers in
colorectal cancer. Aging (Albany NY). 2020 Oct 8;12.(IF:4.831) 2.Chen Xin#*, Liang Huiling, Song Qibin, Xia Leiming, Xuximing, Cao Dedong. Insulin promotes progression of colon cancer by upregulation of ACAT1. Lipids Health Dis. 2018 May 24;17(1):122. (IF:2.663) 3.Chen Xin#*, Song Qibin, Xia Leiming, Xuximing. Synergy of Dendritic Cell Vaccines and Avasimibe in Treatment of Head and Neck Cancer in Mice. Med Sci Monit, 2017. 23: p. 4471-4476. (IF:1.894) 4.Yangyang Hu#, Lin Lu#, Yang Xia#, Xin Chen, Alfred E. Chang, Robert, E. Hollingsworth, Elaine Hurt, John Owen, Jeffrey S. Moyer, Mark E.P. Prince, Fu Dai, Yangyi Bao, Yi Wang, Joel Whitfield, Jian-Chuan Xia, Shiang Huang*, Max S. Wicha*, Qiao Li*. Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting. Cancer Research, 2016, 76(16): 4661-4672. (IF:9.122) 5.Xia Yang#, Tao Huimin#, Hu Yangyang#, Chen Quanning#, Chen Xin, Xia Leiming, Zhou Li, Wang Yi, Bao Yangyi, Huang Shiang, Ren Xiubao, Lundy Steven K, Dai Fu*, Li Qiao*, Chang Alfred E*. IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways. Oncotarget, 2016, 7(37): 60461-60474. (IF:5.168) 6.Jing Ge#, Wei Zhai#, Bei Cheng*, Ping He, Benling Qi, Han Lu, Yongli Zeng, Xin Chen. InsulinInduces Human Acyl‐Coenzyme A: Cholesterol Acyltransferase1 GeneExpression Via MAP Kinases and CCAAT/Enhancer‐Binding Protein a, Journal of Cellular Biochemistry. 2013, 114(9):2188-2198. (IF:3.062) |
Name | XIN CHEN |
Date of birth | JULY,1981 |
Department | Oncology Department,Renmin Hospital,Wuhan University. |
Title | Associate Chief Physician, Master Tutor |
rm001275@whu.edu.cn | |
TEL | 027-88041911转85015或18171235882 |
Research Direction |
1.
Precise radiotherapy for malignant tumors 2. Lipid metabolism and tumor immune microenvironment |
Personal Profile | She is mainly engaged in the diagnosis and treatment of cancer. She went to the University of Michigan and Sun Yat-sen University Cancer Center, hosted and participated in a number of national/provincial/university natural science funds, and published 30 atticles.By now, she has educated 4 masters. At present, she is currently a class tutor and study tutor of Wuhan University School of Medicine . |
Selected Publications |
1.Liao
F#*, Chen X#, Peng P, Dong W*. RWR-algorithm-based dissection of
microRNA-506-3p and microRNA-140-5p as radiosensitive biomarkers in
colorectal cancer. Aging (Albany NY). 2020 Oct 8;12.(IF:4.831) 2.Chen Xin#*, Liang Huiling, Song Qibin, Xia Leiming, Xuximing, Cao Dedong. Insulin promotes progression of colon cancer by upregulation of ACAT1. Lipids Health Dis. 2018 May 24;17(1):122. (IF:2.663) 3.Chen Xin#*, Song Qibin, Xia Leiming, Xuximing. Synergy of Dendritic Cell Vaccines and Avasimibe in Treatment of Head and Neck Cancer in Mice. Med Sci Monit, 2017. 23: p. 4471-4476. (IF:1.894) 4.Yangyang Hu#, Lin Lu#, Yang Xia#, Xin Chen, Alfred E. Chang, Robert, E. Hollingsworth, Elaine Hurt, John Owen, Jeffrey S. Moyer, Mark E.P. Prince, Fu Dai, Yangyi Bao, Yi Wang, Joel Whitfield, Jian-Chuan Xia, Shiang Huang*, Max S. Wicha*, Qiao Li*. Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting. Cancer Research, 2016, 76(16): 4661-4672. (IF:9.122) 5.Xia Yang#, Tao Huimin#, Hu Yangyang#, Chen Quanning#, Chen Xin, Xia Leiming, Zhou Li, Wang Yi, Bao Yangyi, Huang Shiang, Ren Xiubao, Lundy Steven K, Dai Fu*, Li Qiao*, Chang Alfred E*. IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways. Oncotarget, 2016, 7(37): 60461-60474. (IF:5.168) 6.Jing Ge#, Wei Zhai#, Bei Cheng*, Ping He, Benling Qi, Han Lu, Yongli Zeng, Xin Chen. InsulinInduces Human Acyl‐Coenzyme A: Cholesterol Acyltransferase1 GeneExpression Via MAP Kinases and CCAAT/Enhancer‐Binding Protein a, Journal of Cellular Biochemistry. 2013, 114(9):2188-2198. (IF:3.062) |